Cannabiorcol as a novel inhibitor of the p38/MSK-1/NF-κB signaling pathway, reducing matrix metalloproteinases in osteoarthritis
Open Access
- 9 October 2024
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 135, 156141
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Korea Ministry of SMEs and Startups
- Korea Ministry of Science and ICT
- Korea Institute of Science and Technology
- Korea ministry of food and drug safety
This publication has 31 references indexed in Scilit:
- Novel Δ8-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy MetalsChemical Research in Toxicology, 2021
- YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behaviorExperimental & Molecular Medicine, 2021
- The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated reviewLife Sciences, 2019
- Interleukin-1β signaling in osteoarthritis – chondrocytes in focusCellular Signalling, 2019
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritisNature Reviews Rheumatology, 2010
- The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the ratOsteoarthritis and Cartilage, 2010
- LPS/TLR4 signal transduction pathwayCytokine, 2008
- ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblastsCellular Signalling, 2006
- NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativaPhytochemical Analysis, 2004
- Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of HashishNature, 1971